News | June 03, 2022
GSK to form consumer healthcare business ‘Haleon’
The proposed demerger is the most significant corporate change for GSK in the last 20 years
The proposed demerger is the most significant corporate change for GSK in the last 20 years
Construction will begin in early 2023, and the plant is scheduled to go onstream in 2025
120+ members of multi-disciplinary medical team are trained to provide seamless, outcome driven trauma and emergency care
Besides enhancing workflow operations by connecting scientists with their lab instruments and data, digitalization holds the potential to acceleratee long-term business growth
Govt. has set a target to increase the number of JanAushadhi Kendras to 10,000 by March 2024
Low-dose atropine has emerged as an effective approach to slow the progression of myopia in children
This expansion announcement came right after raising series B funding of $27 Mn in a round led by Fundamentum Partnership, earlier this month.
Dupixent would be the first and only medicine specifically indicated to treat prurigo nodularis in the U.S., if approved
This agreement is in addition to the $92 million filling line expansion announced in November 2021
Pharmaceutical manufacturer uses Veeam solutions to accelerate mission-critical backups by 95% and restore data in minutes, not hours
Subscribe To Our Newsletter & Stay Updated
